Key Evidenced‑Based Clinical Features of Systemic Lupus Erythematosus

Overall Disease Presentation

• Systemic lupus erythematosus (SLE) displays an extremely variable clinical picture that can involve virtually any organ system, with mucocutaneous manifestations, arthritis, and renal disease being the most frequently observed features【@1】.

Constitutional Symptoms

• Fever in patients with SLE must prompt immediate exclusion of infection, particularly when C‑reactive protein exceeds 50 mg/L, because fever alone cannot be reliably attributed to lupus activity【@3】.

Cutaneous Manifestations

• Both LE‑specific lesions (acute, subacute, chronic discoid, and intermittent cutaneous lupus) and non‑specific skin findings are characteristic of SLE【@5】.
• Accurate diagnosis of cutaneous lupus often requires assessment by an experienced dermatologist and a skin biopsy to differentiate it from mimicking dermatologic conditions【@5】.

Renal Involvement

• Renal flares occur in up to 45 % of patients with established lupus nephritis, at an incidence of approximately 0.1–0.2 flares per patient per year【@5】.
• Hypertension is a common clinical indicator of renal disease activity in SLE【@5】.
• Five‑year renal survival is influenced by age, ethnicity, baseline serum creatinine, presence of hypertension, complement C3 levels, and histologic activity/chronicity indices on kidney biopsy【@5】.

Hematologic Manifestations

• Severe cytopenias—including marked anemia, thrombocytopenia, leukopenia, and lymphopenia—signal active disease and are associated with a poorer prognosis【@3】.

Neuropsychiatric Involvement

• Neurological involvement is frequent in SLE and encompasses central and peripheral nervous system manifestations【@5】.
• The most common neuropsychiatric syndromes are:
  • Headache【@5】
  • Mood disorders (depression, psychosis)【@5】
  • Cerebrovascular disease【@5】
  • Transverse myelitis【@5】
  • Seizures【@3】
  • Cognitive impairment (memory, attention, concentration, word‑finding deficits)【@4】
  • Acute confusional state【@2】
  • Cranial or peripheral neuropathy【@3】.
• No specific validated instrument exists for routine neuropsychiatric assessment in SLE; clinical monitoring relies primarily on detailed history taking【@5】.

Cardiovascular Risk

• Patients with SLE have a markedly increased risk of premature atherosclerosis and cardiovascular disease that cannot be fully explained by traditional risk factors alone【@2】.
• Hypertension prevalence in SLE ranges from 11.5 % to 75 %【@2】.
• Dyslipidemia prevalence in SLE also ranges from 11.5 % to 75 %【@2】.

Gastrointestinal Involvement

• Gastrointestinal manifestations are less common than other organ system involvement in SLE, but may include mesenteric vasculitis, pancreatitis, and hepatitis【@2】.

Serologic/Immunologic Indicators

• Low complement levels (C3, C4) are associated with active disease activity but do not predict future flares【@3】.

Associated Conditions and Complications

• Antiphospholipid antibodies, when present, significantly increase the risk of thrombosis and pregnancy complications【@2】.
• Osteoporosis affects 4 %–24 % of SLE patients, with vertebral fracture rates between 7.6 % and 37 %【@2】.
• Cancer incidence is elevated in SLE, notably:
  • Hematologic malignancies【@3】
  • Cervical, breast, and lung cancers【@2】.
• Infection risk is substantially heightened due to both disease‑related immune dysregulation and immunosuppressive therapy【@2】.

Clinical Pitfalls

• The clinical picture of SLE is highly heterogeneous and can evolve over time within the same individual, necessitating continuous vigilance【@1】.
• Distinguishing active disease from irreversible organ damage, drug toxicity, and intercurrent infections is essential for appropriate management【@4】【@2】【@1】.
• Fever should never be presumed to stem solely from lupus activity; systematic infection work‑up is mandatory, especially when CRP exceeds 50 mg/L【@3】.
• Numerous non‑lupus conditions can mimic SLE manifestations, often requiring thorough evaluation and, when indicated, tissue diagnosis such as biopsy【@5】.

Key Clinical Features and Complications of Systemic Lupus Erythematosus

Mucocutaneous Manifestations

• Both lupus‑specific lesions (acute, subacute, chronic discoid, and intermittent cutaneous lupus) and non‑specific skin findings characterize SLE, requiring assessment by an experienced dermatologist and often a skin biopsy for accurate differentiation from mimicking conditions. 1

Renal Manifestations

• Lupus nephritis affects up to 45 % of patients, with renal flares occurring at an incidence of roughly 0.1–0.2 flares per patient‑year. 1
• Hypertension commonly signals active renal disease. 1
• Proteinuria, abnormal urinary sediment (cellular casts, hematuria), and elevated serum creatinine indicate kidney involvement. 1
• Five‑year renal survival is influenced by age, ethnicity, baseline serum creatinine, presence of hypertension, complement C3 levels, and histologic activity/chronicity indices on kidney biopsy. 1

Hematologic Abnormalities

• Severe cytopenias—including marked anemia, thrombocytopenia, leukopenia, and lymphopenia—indicate active disease and are linked to poorer prognosis and higher infection risk. 1
• Lymphopenia is especially common and correlates with disease activity. 1

Neuropsychiatric Involvement

• Neurological involvement is frequent in SLE, encompassing both central and peripheral nervous system manifestations. 1
• The most common neuropsychiatric syndromes are:
  
  • Headache (most frequent). 1
  • Mood disorders such as depression and psychosis. 1
  • Cognitive impairment affecting memory, attention, concentration, and word‑finding. 1
  • Seizures. 2
  • Cerebrovascular disease, including stroke. 1
  • Acute confusional state or coma. 2
  • Transverse myelitis/myelopathy. 2
  • Cranial or peripheral neuropathy. 2
  • Optic neuritis. 2
• No specific validated instrument exists for routine neuropsychiatric assessment; clinical monitoring relies primarily on detailed history taking. 1

Serologic and Immunologic Indicators

• Low complement levels (C3, C4) are associated with active disease but do not predict future flares. 1
• Anti‑dsDNA antibodies correlate with disease activity, particularly renal involvement. 1
• Antiphospholipid antibodies markedly increase the risk of thrombosis and pregnancy complications. 2

Associated Complications and Comorbidities

• Infections represent a major cause of morbidity and mortality due to both disease‑related immune dysregulation and immunosuppressive therapy. 2
• Cancer incidence is elevated in SLE, especially non‑Hodgkin lymphoma, cervical, breast, and lung cancers. 2
• Avascular necrosis, particularly of the femoral head, occurs with increased frequency. 2
• Diabetes mellitus risk is heightened, often related to chronic glucocorticoid use. 2